Patent Application Naming AI as Inventor in India – Dr. Kalyan C. Kankanala opposes Stephen Thaler’s Patent application

Patent Application Naming AI as Inventor in India – Dr. Kalyan C. Kankanala opposes Stephen Thaler’s Patent application Featured image for Patent Application Naming AI as Inventor in India – Dr. Kalyan C. Kankanala opposes Stephen Thaler’s Patent application

The question of whether Artificial Intelligence (AI) can be an inventor in a patent application has been the subject of debate for a while now. There are arguments for and against this issue, and a few models have been proposed to resolve some of the legal problems. Read more

Read more about Patent Application Naming AI as Inventor in India – Dr. Kalyan C. Kankanala opposes Stephen Thaler’s Patent application

Anticipation – Mere Presence of Elements Insufficient; Arrangement of Elements Imperative

Anticipation – Mere Presence of Elements Insufficient; Arrangement of Elements Imperative Featured image for Anticipation – Mere Presence of Elements Insufficient; Arrangement of Elements Imperative

This post was first published on July 15, 2014.   How is the novelty of an invention established? Another question with a similar connotation is...

Read more about Anticipation – Mere Presence of Elements Insufficient; Arrangement of Elements Imperative

Patentability and Section 3(d), History of Patent Law in India, Patentability of Imatinib Masylate in Beta Crystalline Form – Novartis Case Abridged by Dr. Kalyan C. Kankanala

Patentability and Section 3(d), History of Patent Law in India, Patentability of Imatinib Masylate in Beta Crystalline Form – Novartis Case Abridged by Dr. Kalyan C. Kankanala Featured image for Patentability and Section 3(d), History of Patent Law in India, Patentability of Imatinib Masylate in Beta Crystalline Form – Novartis Case Abridged by Dr. Kalyan C. Kankanala

This abridged version of the Novartis case was used by Dr. Kalyan C. Kankanala to explain to the students of UPES, the patentability requirements under the...

Read more about Patentability and Section 3(d), History of Patent Law in India, Patentability of Imatinib Masylate in Beta Crystalline Form – Novartis Case Abridged by Dr. Kalyan C. Kankanala